[Federal Register Volume 88, Number 7 (Wednesday, January 11, 2023)]
[Notices]
[Pages 1583-1584]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-00408]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2023-0001]


Advisory Committee to the Director, Centers for Disease Control 
and Prevention

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting and request for comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Advisory Committee to the 
Director, Centers for Disease Control and Prevention (ACD, CDC). This 
meeting is open to the public. The meeting will be webcast live via the 
World Wide Web.

DATES: The meeting will be held on February 7, 2023, from 10 a.m. to 
3:30 p.m., EST (times subject to change). The public may submit written 
comments on or before January 27, 2023.

ADDRESSES: Information for accessing the webcast will be available at 
https://www.cdc.gov/about/advisory-committee-director/.
    Written comments: You may submit comments, identified by Docket No. 
CDC-2023-0001, by any of the following methods. Do not submit comments 
for the docket by email. CDC does not accept comments for the docket by 
email.
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: Kerry Caudwell, DPA, Centers for Disease Control and 
Prevention, 1600 Clifton Road NE, MS H21-10, Atlanta, Georgia 30329-
4027. Attn: Docket number CDC-2023-0001.
    Instructions: All submissions received must include the Agency name 
and Docket Number. All relevant comments received in conformance with 
the https://www.regulations.gov suitability policy will be posted 
without change to https://www.regulations.gov, including any personal 
information provided. For access to the docket to read background 
documents or comments received, go to https://www.regulations.gov. 
Written public comments submitted up to 72 hours prior to the ACD 
meeting will be provided to ACD members before the meeting. Written 
comments received in advance of the meeting will be included in the 
official record of the meeting.

FOR FURTHER INFORMATION CONTACT: Kerry Caudwell, DPA, Office of the

[[Page 1584]]

Chief of Staff, Centers for Disease Control and Prevention, 1600 
Clifton Road NE, MS H21-10, Atlanta, Georgia 30329-4027, Telephone: 
(404) 639-0390; Email Address: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Advisory Committee to the Director (ACD), CDC, shall 
advise the Secretary, HHS, and the Director, CDC, on policy and broad 
strategies that will enable CDC to fulfill its mission of protecting 
health through health promotion, prevention, and preparedness. The 
committee recommends ways to prioritize CDC's activities, improve 
results, and address health disparities. It also provides guidance to 
help CDC work more effectively with its various private and public 
sector constituents to make health protection a practical reality.
    Matters To Be Considered: The agenda will include discussions on 
CDC's current work and priorities as they relate to health equity and 
data and surveillance recommendations to the Department of Health and 
Human Services and CDC Director. The agenda also includes a laboratory 
workgroup update with recommended action steps to the full ACD 
Committee, along with an update on the public health infrastructure 
grant. Agenda items are subject to change as priorities dictate.

Public Participation

    Interested persons or organizations are invited to participate by 
submitting written views, recommendations, and data. Please note that 
comments received, including attachments and other supporting 
materials, are part of the public record and are subject to public 
disclosure. Comments will be posted on https://www.regulations.gov. 
Therefore, do not include any information in your comment or supporting 
materials that you consider confidential or inappropriate for public 
disclosure. If you include your name, contact information, or other 
information that identifies you in the body of your comments, that 
information will be on public display. CDC will review all submissions 
and may choose to redact, or withhold, submissions containing private 
or proprietary information such as Social Security numbers, medical 
information, inappropriate language, or duplicate/near duplicate 
examples of a mass-mail campaign. CDC will carefully consider all 
comments submitted into the docket.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-00408 Filed 1-10-23; 8:45 am]
BILLING CODE 4163-18-P